DEFINITIVE PROXY STATEMENT

Company

TG THERAPEUTICS, INC.

Filed

July 17, 2001

Period of Report

August 8, 2001

Accession Number

0000922423-01-500522

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →